Alzheimer’s disease drug-development pipeline: few candidates, frequent failures
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cognitive Neuroscience,Clinical Neurology,Neurology
Reference21 articles.
1. Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model†
2. Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
3. What Can Be Inferred from the Interruption of the Semagacestat Trial for Treatment of Alzheimer's Disease?
4. Increasing the success rate for Alzheimer's disease drug discovery and development
5. Alzheimer's therapeutics: Continued clinical failures question the validity of the amyloid hypothesis—but what lies beyond?
Cited by 1441 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A comparative study of goji berry and ashwagandha extracts effects on promoting neural stem cell proliferation and reducing neuronal cell death;Food & Medicine Homology;2025-09
2. Revolutionizing neurotherapeutics: Nanocarriers unveiling the potential of phytochemicals in Alzheimer's disease;Neuropharmacology;2024-11
3. Evolving significance of kinase inhibitors in the management of Alzheimer's disease;European Journal of Pharmacology;2024-09
4. A Systematic Online Living Evidence Summary of experimental Alzheimer’s disease research;Journal of Neuroscience Methods;2024-09
5. Developing diagnostic biomarkers for Alzheimer's disease based on histone lactylation-related gene;Heliyon;2024-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3